THD

Indicazioni Sito Web Contatta l'azienda

Benvenuti nella page di THD. Ricerca e innovazione per la Coloproctologia. Welcome to THD page. Research and Innovation for Coloproctology.

THD offre soluzioni mediche innovative per la diagnosi e il trattamento delle più comuni patologie colorettali. L’attenzione ai bisogni di medici e pazienti insieme alla continua ricerca e all’utilizzo delle tecnologie più avanzate sono le fonti di ispirazione di THD. La nostra vision è fare la differenza nel campo della coloproctologia con procedure mini-invasive all’avanguardia per la diagnosi e il trattamento dei disturbi colorettali. La nostra mission è migliorare gli standard internazionali per la diagnosi e il trattamento di numerose patologie colorettali, grazie alla costante ricerca scientifica e tecnologica. THD S.p.A. is a well-known brand in the scientific world, with innovative healthcare solutions for the advanced diagnosis and treatment of colorectal disorders. The attention to patient’s and surgeon’s needs, together with ongoing research and cutting-edge technology are THD’s sources of inspiration. Our vision is leading coloproctology with advanced and minimally-invasive procedures for the diagnosis and treatment of colorectal disorders. Our mission is to globally improve healthcare standards for the diagnosis and treatment of colorectal diseases through constant technological advances and scientific research. THD: a global healthcare company made of people and at the service of people.

30/10/2026

𝗨𝗘𝗚 𝗪𝗲𝗲𝗸 𝟮𝟬𝟮𝟲 | 𝗘𝗻𝗱𝗼𝗮𝗻𝗮𝗹 𝗨𝗹𝘁𝗿𝗮𝘀𝗼𝘂𝗻𝗱 𝗖𝗼𝘂𝗿𝘀𝗲 | 17-20 October, Barcelona

From October 17 to 20, 2026, THD took part in the UEG Week 2026, held at the Fira de Barcelona, one of the largest and most influential events in the field of gastroenterology at a European and global level. 🌟

🎤 Within the framework of the congress, THD was proud to actively contribute to the 𝗘𝗻𝗱𝗼𝗮𝗻𝗮𝗹 𝗨𝗹𝘁𝗿𝗮𝘀𝗼𝘂𝗻𝗱 𝗖𝗼𝘂𝗿𝘀𝗲, held on Sunday October 18 and Monday October 19, under the direction of Prof. Yogesh Vashist and Prof. Giulio Santoro, together with a distinguished international faculty.

The course offered an in-depth journey through the role of imaging in the diagnosis and management of pelvic floor disorders and anore**al pathologies, combining theory, case presentations and hands-on exercises on key topics such as:

➡️ Ultrasonographic imaging techniques: endoa**l, endore**al, endovaginal and dynamic transperineal ultrasound
➡️ Normal ultrasound of the a**l ca**l, re**um and pelvic floor
➡️ Ultrasound assessment of OASIS and faecal incontinence
➡️ A**l ultrasound for the evaluation of a**l fistula
➡️ Role of ultrasound in staging of re**al cancer
➡️ Ultrasound assessment of obstructed defaecation and a unitary approach to pelvic floor disorders

🔬 A key moment of the course was the hands-on session, where participants had the opportunity to practice endoa**l ultrasound, anore**al manometry and videoanoscopy, strengthening their skills in the diagnostic workup of anore**al and pelvic floor conditions.

The event confirmed once again THD’s ongoing commitment to innovation, scientific collaboration, and continuous medical education in the field of coloproctology and pelvic floor imaging.

**lultrasound

30/10/2026

🔖 𝗛𝗶𝗴𝗵 𝗥𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗔𝗻𝗼𝘀𝗰𝗼𝗽𝘆 𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 in 𝗡𝗶𝗰𝗲

On October 14–15, 2026, Dr. Mariangela Desantis led a High Resolution Anoscopy (HRA) Training at Clinique Kantys Santa Maria in Nice.

A dedicated session held in French, bringing together clinical expertise and hands-on learning around the HRA procedure, for the early diagnosis and minimally invasive management of a**l precancerous lesions.

A sincere thank you to Dr. Desantis for her ongoing commitment to education and to the participating physician for the engagement and valuable exchange throughout the course.

**lcancer

06/10/2026

𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗔𝗡𝗗 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁

The terms Research & Development (R&D) are often used as a pair, almost suggesting an overlap or a continuity that blurs their boundaries and areas of activity. That "&" can be a trap: it creates a link between two strategic elements that stem from very distinct premises.

𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝘀 𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝘆 𝗰𝘂𝗿𝗶𝗼𝘀𝗶𝘁𝘆. It takes many forms, from basic to applied research, but they all share the same impulse: someone is struck by a phenomenon or a question and sets out in search of an answer, to understand more deeply.

𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗶𝘀 𝗱𝗿𝗶𝘃𝗲𝗻 𝗯𝘆 𝗱𝗲𝘀𝗶𝗿𝗲. It starts from a point, from an observation, and glimpses a direction: a goal that, in the eyes of those pursuing it, represents an improvement over the starting condition.

The "&" flattens and merges two different ways of engaging with reality, with the risk of diluting the distinctive traits of two profoundly different processes. The people who carry them out may also differ in their qualities, but all of them need a spirit of observation, humility, a desire for improvement, and rigor.

This is why we prefer to replace the "&" with an "AND". It is not simply a change of symbol: the "&" merges two words into an acronym, while "AND" places them side by side, allowing each to keep its own identity. In this way, "AND" becomes the meeting point of two ways of looking at reality, ways that, when well integrated, become the true strategic engine of a company.

𝗧𝗵𝗶𝘀 𝗶𝘀 𝗮𝗹𝗹 𝘁𝗵𝗲 𝗺𝗼𝗿𝗲 𝘁𝗿𝘂𝗲 𝘄𝗵𝗲𝗻 𝗶𝘁 𝗰𝗼𝗺𝗲𝘀 𝘁𝗼 𝗵𝗲𝗮𝗹𝘁𝗵.

Being visionary means letting ourselves be amazed by the beauty of the human body, with the curiosity of those who seek to understand it and the desire to turn that knowledge into new standards of care. 𝗧𝗼 𝗺𝗮𝗸𝗲 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀' 𝗹𝗶𝘃𝗲𝘀 𝗯𝗲𝘁𝘁𝗲𝗿, 𝗼𝗿 𝘀𝗶𝗺𝗽𝗹𝘆 𝗺𝗼𝗿𝗲 𝗵𝘂𝗺𝗮𝗻.

𝗧𝗵𝗶𝘀 𝗶𝘀 𝗵𝗼𝘄 𝘄𝗲 𝘀𝗲𝗲 𝘁𝗵𝗶𝗻𝗴𝘀. 𝗔𝗻𝗱 𝘁𝗵𝗶𝘀 𝗶𝘀 𝗵𝗼𝘄 𝘄𝗲 𝗰𝗿𝗲𝗮𝘁𝗲 𝘃𝗮𝗹𝘂𝗲.

06/10/2026

Proud to have been part of the 𝗢𝗵𝗶𝗼 𝗩𝗮𝗹𝗹𝗲𝘆 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗖𝗼𝗹𝗼𝗻 𝗮𝗻𝗱 𝗥𝗲𝗰𝘁𝗮𝗹 𝗦𝘂𝗿𝗴𝗲𝗼𝗻𝘀 𝗔𝗻𝗻𝘂𝗮𝗹 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 this past Saturday at The Ohio State University!
It was a packed day of learning at The James Cancer Hospital, and our regional representative, Alli Loretto, was glad to be there representing THD America.

The 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 covered a lot of ground:
🔹 Neoplasia: young-onset colon cancer, AI in colonoscopy, ctDNA and minimal residual disease, the lateral lymph node question in re**al cancer, a**l cancer screening, and chemotherapy sequencing in TNT
🔹 Pelvic floor and anore**al: sphincteroplasty in the era of sacral neuromodulation, obstructed defecation, new anore**al techniques, and pilonidal approaches
🔹 IBD and benign disease: the changing landscape of colore**al training, IBD medical management, and the evolving role of surgery in diverticulitis
🔹 Resident abstract session and award ceremony, a great look at the next generation of colore**al surgeons

At our booth, Alli presented:
✅ the new THD integrated mobile platform for anore**al manometry, digital video anoscopy, and ultrasound;
✅ our innovative approach to High-Resolution Anoscopy (HRA) for the early diagnosis and minimally invasive treatment of precancerous a**l lesions;
✅ our THD Anolift procedure for minimally invasive hemorrhoid treatment.

Thank you to the organizers and The Ohio State University for hosting, to the speakers for sharing their expertise, and to everyone who stopped by to talk technology and ask great questions. Looking forward to the next meeting!

**alSurgery **alHealth

02/10/2026

📌 𝗧𝗛𝗗 𝗮𝘁 𝘁𝗵𝗲 𝗘𝗦𝗖𝗣 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗣𝗿𝗮𝗴𝘂𝗲

From 23 to 25 September 2026, the Prague Congress Centre hosted the Annual Meeting of the ESCP (European Society of Coloproctology), the leading scientific event for colore**al surgery and proctology in Europe.

THD attended as a Diamond Sponsor and brought its latest innovations to the heart of the European coloproctology community. The ESCP Annual Meeting brings together surgeons, researchers and clinicians from across Europe and beyond to share the latest evidence and advances in the field.

For THD, taking part as a Diamond Sponsor in Prague meant strong international visibility and a further step in consolidating a position built over the years on clinical quality and continuous innovation.

At Booth 5 in the exhibition area, THD presented its technologies to colore**al surgeons from all over the world.

👥🔬 One of the highlights of THD's participation was the 𝗦𝗮𝘁𝗲𝗹𝗹𝗶𝘁𝗲 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 "𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗢𝗳𝗳𝗶𝗰𝗲-𝗕𝗮𝘀𝗲𝗱 𝗣𝗿𝗼𝗰𝘁𝗼𝗹𝗼𝗴𝘆: 𝗙𝗼𝘂𝗿 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀. 𝗢𝗻𝗲 𝗡𝗲𝘄 𝗩𝗶𝘀𝗶𝗼𝗻", held on Thursday 24 September in South Hall 2 and chaired by Filippo Bastia, CEO of THD. The symposium presented four THD procedures that are changing how proctological conditions are treated in the office setting:

🔹 𝗧𝗛𝗗 𝗦𝗲𝗹𝗳 𝗕𝗮𝗻𝗱𝘆
Beyond Blind Banding: Redefining Rubber Band Ligation
🎤 Speaker: Dr. Alex Leo

🔹 𝗧𝗛𝗗 𝗟𝗮𝘀𝗲𝗥𝗮𝗴
Redefining Treatment for A**l Fissures: Where Vision Meets Laser Technology
🎤 Speaker: Dr. Simone Orlandi

🔹 𝗧𝗛𝗗 𝗛𝗲𝗺𝗼𝗿𝗙𝗹𝗼𝘄
Injection-Based Office Surgery (IBOS)
🎤 Speaker: Dr. Gaetano Gallo

🔹 𝗧𝗛𝗗 𝗖𝗼𝘃𝗲𝗿𝗙𝗹𝗼𝘄
The Missing Interface: Bringing Precision Imaging to the Point of Care
🎤 Speaker: Dr. Dr Adam Aboalkaz

The session ended with an open Q&A, where attendees discussed the clinical benefits and future potential of these procedures with the speakers.

THD's presence in this setting confirms its role as an active partner in clinical innovation to shape new diagnostic and therapeutic practices in coloproctology.

🌟 A heartfelt thank you to all those who visited our stand and who contribute daily to the progress and improvement of medical care on a global level.

**alSurgery

28/07/2026

𝗖𝗘𝗢 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀
𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲: 𝗧𝗵𝗲 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝗳𝗼𝗿 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲

In the years ahead, Artificial Intelligence won't be a choice: it will be a circumstance none of us can escape.

We're witnessing a revolution whose impact will exceed even that of the Industrial Revolution: an era that reshaped human anthropology and redrew the global order. Today, AI is doing the same on a personal and professional level alike. Soon, a product or service that isn't powered by AI will feel like the exception.

Medicine, scientific research, and medical devices are no exception. In fact, this may be where AI makes its greatest contribution, using algorithms to distill decades of clinical experience into tools available to everyone.

But this requires a fundamental shift in mindset. We must "𝘵𝘩𝘪𝘯𝘬 𝘪𝘯 𝘈𝘐", treating it not as a posthumous add-on, but as a genuine new industrial paradigm. And that demands clear strategies: long-term commitment, significant investment, trained talent, new skills, and certified data to feed the algorithms.

We won't be caught unprepared. For years, we've been working intensely to equip our technologies with AI-based solutions. Along the way, we've discovered something powerful: AI pushes everyone to raise the bar to imagine solutions and products that were previously unthinkable.

Being a leader means facing these challenges with awareness of our potential, but also with the humility to never feel "at the finish line."

This is the challenge for excellence. And it's one we intend to meet head-on.

28/07/2026

📌 𝗧𝗛𝗗 𝗶𝗻 𝗧𝗮𝗺𝗽𝗮 𝗳𝗼𝗿 𝗔𝗦𝗖𝗥𝗦 𝟮𝟬𝟮𝟲

From 9 to 12 May 2026, the Tampa Convention Center hosted the Annual Scientific Meeting of the ASCRS, the American Society of Colon and Re**al Surgeons, one of the world's most authoritative scientific events for colore**al surgery and a**l disorders. THD attended as an official sponsor, bringing its innovative techniques to the heart of the American coloproctology community.

The ASCRS Annual Scientific Meeting is the leading North American congress dedicated to colore**al surgery, drawing thousands of specialists from around the world every year. THD's participation as a sponsor at the Tampa 2026 meeting marked a moment of strong international visibility for the company and its technologies, consolidating a position built over the years on clinical quality and continuous innovation.

Within the Innovation Center, the large exhibition space alongside the scientific programme, THD presented its techniques to hundreds of colore**al surgeons, offering hands-on demonstrations and opportunities for direct dialogue with the American and international professionals in attendance. It was a valuable occasion to give a high-profile audience a close-up look at THD's instruments.

👥🔬 Among the most significant moments of THD's participation in the congress was the Satellite Symposium dedicated to High-Resolution Anoscopy (HRA). A scientific event, organised on the sidelines of the main programme that brought together experts and clinicians to explore the state of the art of this technology in the diagnosis and treatment of a**l precancerous lesions.

HRA is today recognised internationally as the gold standard for the screening and management of a**l dysplasia, particularly in at-risk patients. The Satellite Symposium provided the opportunity to present the most recent clinical evidence, discuss practical cases and exchange views on the future prospects of this technique, with THD technology at the centre of the scientific debate.

THD's presence in this setting confirms the company's role not only as a manufacturer of medical devices, but as an active partner in international clinical research, capable of contributing concretely to the evolution of diagnostic and therapeutic practices in coloproctology.

🌟 Participation in ASCRS 2026 forms part of an increasingly structured international presence strategy, which sees THD playing a leading role at the world's most important industry congresses. Tampa represented a further step along this path: an opportunity to strengthen relationships with American opinion leaders, gather feedback directly from the field and continue positioning THD's techniques as the reference standard in modern coloproctological surgery.

15/04/2026

𝗖𝗘𝗢 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀: 𝗧𝗛𝗗 𝟮.𝟬, 𝗮 𝗩𝗶𝘀𝗶𝗼𝗻 𝗧𝗵𝗮𝘁 𝗚𝗼𝗲𝘀 𝗕𝗲𝘆𝗼𝗻𝗱 𝗕𝗼𝘂𝗻𝗱𝗮𝗿𝗶𝗲𝘀 🌐✨

The transition from THD to THD 2.0 is not just an organizational evolution:
it is a broader perspective, a vision that goes beyond the boundaries of coloproctology toward interconnected medical horizons.

Over 20 years of research, development and clinical presence, we have learned that many conditions are not limited to a single anatomical region.

The pelvic floor, a crossroads between the colon, urinary system and gynecology, is the perfect example.

This awareness guides us toward a new phase: extending our expertise to neighboring fields, with technological innovation and quality treatments that truly improve people's lives. 💡

We are not changing course, but evolving consistently: we listen to healthcare professionals, we observe and we learn.

The synergy between colore**al surgery, gynecology and urology becomes the fertile ground for integrated, personalized solutions. New collaborations with specialists emerge, shared research lines and tools designed for the complexity of the pelvic floor. 🔬

Our mission remains unchanged: the patient at the center. Today, however, with a broader view of the body's functional balance.

THD 2.0 brings to new fields the passion, rigor and innovation that have made it a globally recognized name.

Another step toward the future and innovation, with the patient always in first place.

Filippo Bastia
CEO

09/04/2026

📌 𝗛𝗶𝗴𝗵 𝗥𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗔𝗻𝗼𝘀𝗰𝗼𝗽𝘆 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗖𝗼𝘂𝗿𝘀𝗲 𝗶𝗻 𝗡𝗶𝗰𝗲

On April 7–8, in Nice, Dr. Mariangela Desantis led a High Resolution Anoscopy Advanced Course for two French physicians.

👥🔬This hands-on training, conducted entirely in French, gave participants the opportunity to deepen their expertise in one of the most advanced diagnostic procedures in coloproctology, combining high-resolution imaging with clinical practice in a stimulating and collaborative environment.

🌟 We extend our sincere gratitude to the trainer and all participants whose commitment to professional development continues to elevate the standards of care globally.

03/04/2026

🐣 THD sends its warmest Easter wishes to you and your loved ones.

Indirizzo

Reggio Nell Emilia

Sito Web

https://www.thdlab.com/, https://www.thdlab.fr/, https://www.thdlab.de/, https://www.thdlab.co.uk/, https://www.thdlab.i

Notifiche

Lascia la tua email e sarai tra i primi a sapere quando THD pubblica novità e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.